Absence of cross-tolerance to heroin in morphine-tolerant mice.

Mice implanted with morphine pellets demonstrated a 30-fold increase in tolerance to subcutaneously administered morphine but showed no cross-tolerance to subcutaneously administered heroin. When given morphine intracerebroventricularly, the mice showed no tolerance to morphine or cross-tolerance to heroin. These observations depended on the presence of the morphine pellet. If the pellets were removed prior to determinations of potency, the expected responses--tolerance to morphine and cross-tolerance to heroin--were obtained. The blood-brain barrier may be a prime site for the expression of morphine tolerance in mice.

[1]  A. Herz,et al.  Opiate antagonist--receptor interaction unchanged by acute or chronic opiate treatment. , 1979, European journal of pharmacology.

[2]  A. Takemori,et al.  Enhanced naloxone potency and the development of narcotic tolerance. , 1979, European journal of pharmacology.

[3]  A. Takemori,et al.  Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment. , 1978, The Journal of pharmacology and experimental therapeutics.

[4]  R. Tallarida,et al.  The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine. , 1978, The Journal of pharmacology and experimental therapeutics.

[5]  L. Harris,et al.  Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance. , 1978, The Journal of pharmacology and experimental therapeutics.

[6]  S. Snyder,et al.  Opiate receptor binding--enhancement by opiate administration in vivo. , 1976, Biochemical pharmacology.

[7]  A. Herz,et al.  Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents. , 1975, Life sciences.

[8]  L. Harris,et al.  Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. , 1975, Journal of Pharmacology and Experimental Therapeutics.

[9]  A. Lajtha,et al.  Paradoxical Effects after Microinjection of Morphine in the Periaqueductal Gray Matter in the Rat , 1974, Science.

[10]  A. Takemori,et al.  Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine. , 1974, The Journal of pharmacology and experimental therapeutics.

[11]  H. Loh,et al.  Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development. , 1974, Life sciences.

[12]  W. Klee,et al.  Narcotic Receptor Sites in Morphine-dependent Rats , 1974, Nature.

[13]  E. J. Simon,et al.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Bloch,et al.  Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats. , 1973, The Journal of pharmacology and experimental therapeutics.

[15]  E. Eidelberg,et al.  Morphine Tolerance and Dependence Induced by Intraventricular Injecfion , 1971, Science.

[16]  A. Goldstein,et al.  Tolerance to Opioid Narcotics: Time Course and Reversibility of Physical Dependence in Mice , 1971, Nature.

[17]  L. Harris,et al.  The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. , 1970, The Journal of pharmacology and experimental therapeutics.

[18]  H. Teschemacher,et al.  Structure-activity correlations of morphine-like analgetics based on efficiencies following intravenous and intraventricular application. , 1970, Journal of medicinal chemistry.

[19]  K. Albus,et al.  Interaction between morphine and morphine antagonists after systemic and intraventricular application. , 1970, European journal of pharmacology.

[20]  R. D. Gibson,et al.  Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. , 1970, Journal of pharmaceutical sciences.

[21]  H. Loh,et al.  Simultaneous quantitative assessment of morphine tolerance and physical dependence. , 1969, The Journal of pharmacology and experimental therapeutics.

[22]  C. Gorodetzky,et al.  Physiologic disposition of H3-cyclazocine in nontolerant, tolerant and abstinent dogs. , 1966, The Journal of pharmacology and experimental therapeutics.

[23]  C. Kornetsky,et al.  DEVELOPMENT AND LOSS OF TOLERANCE TO MORPHINE IN THE RAT AFTER SINGLE AND MULTIPLE INJECTIONS. , 1964, The Journal of pharmacology and experimental therapeutics.

[24]  L. A. Woods,et al.  Distribution of N-C-14-methyl labeled morphine. I. In central nervous system of nontolerant and tolerant dogs. , 1962, The Journal of pharmacology and experimental therapeutics.

[25]  J. Young,et al.  The pharmacologic effects of heroin in relationship to its rate of biotransformation. , 1960, The Journal of pharmacology and experimental therapeutics.

[26]  J. Axelrod,et al.  Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine. , 1959, The Journal of pharmacology and experimental therapeutics.

[27]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[28]  B. Silvestrini,et al.  Preventive action of proxazole in experimentally induced renal hypertension in rats. , 1971, Japanese journal of pharmacology.

[29]  V. J. Lotti,et al.  Acute tolerance to morphine following systemic and intracerebral injection in the rat. , 1966, International journal of neuropharmacology.